Jim Simons Denali Therapeutics Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$16.2 - $23.18 $4.96 Million - $7.09 Million	-305,905 Reduced 65.39%	161,946 $3.48 Million
Q3 2023 Nov 14, 2023	BUY	$20.63 - $30.17 $1,052 - $1,538	51 Added 0.01%	467,851 $9.65 Million
Q2 2023 Aug 11, 2023	BUY	$23.37 - $32.96 $1.4 Million - $1.97 Million	59,700 Added 14.63%	467,800 $13.8 Million
Q1 2023 May 12, 2023	BUY	$21.91 - $32.67 $3.47 Million - $5.18 Million	158,500 Added 63.5%	408,100 $9.4 Million
Q4 2022 Feb 13, 2023	SELL	$26.28 - $33.92 $3.75 Million - $4.84 Million	-142,600 Reduced 36.36%	249,600 $6.94 Million
Q3 2022 Nov 14, 2022	BUY	$25.97 - $38.53 $3.6 Million - $5.34 Million	138,700 Added 54.71%	392,200 $12 Million
Q2 2022 Aug 12, 2022	BUY	$20.88 - $35.19 $2.73 Million - $4.61 Million	130,900 Added 106.77%	253,500 $7.46 Million
Q1 2022 May 13, 2022	BUY	$29.0 - $47.27 $1.98 Million - $3.23 Million	68,300 Added 125.78%	122,600 $3.94 Million
Q4 2021 Feb 11, 2022	SELL	$42.59 - $55.02 $1.76 Million - $2.27 Million	-41,300 Reduced 43.2%	54,300 $2.42 Million
Q3 2021 Nov 12, 2021	BUY	$48.48 - $78.23 $4.08 Million - $6.58 Million	84,100 Added 731.3%	95,600 $4.82 Million
Q2 2021 Aug 13, 2021	SELL	$50.3 - $78.44 $12.8 Million - $20 Million	-254,400 Reduced 95.68%	11,500 $902,000
Q1 2021 May 13, 2021	BUY	$53.8 - $81.53 $14.3 Million - $21.7 Million	265,900 New	265,900 $15.2 Million
Q4 2020 Feb 10, 2021	SELL	$36.89 - $93.56 $1.9 Million - $4.82 Million	-51,500 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$23.13 - $38.84 $1.19 Million - $2 Million	51,500 New	51,500 $1.85 Million
Q3 2019 Nov 13, 2019	SELL	$15.32 - $21.92 $965,160 - $1.38 Million	-63,000 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$18.5 - $28.14 $1.17 Million - $1.77 Million	63,000 New	63,000 $1.31 Million

Others Institutions Holding DNLI

# of Institutions

227

Shares Held

119M

Call Options Held

60.6K

Put Options Held

48.4K

Baillie Gifford & CO

13.3M
Shares

$287 Million
0.3% of portfolio
Black Rock Inc. New York, NY

13.2M
Shares

$283 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

11.2M
Shares

$240 Million
0.01% of portfolio
Wellington Management Group LLP Boston, MA

10.7M
Shares

$231 Million
0.06% of portfolio
Capital Research Global Investors Los Angeles, CA

7.91M
Shares

$170 Million
0.05% of portfolio

View Full List

About Denali Therapeutics Inc.

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

More about DNLI

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account